Clarety Kaseke

758 total citations · 1 hit paper
5 papers, 231 citations indexed

About

Clarety Kaseke is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Clarety Kaseke has authored 5 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Infectious Diseases and 2 papers in Virology. Recurrent topics in Clarety Kaseke's work include SARS-CoV-2 and COVID-19 Research (3 papers), Immunotherapy and Immune Responses (3 papers) and HIV Research and Treatment (2 papers). Clarety Kaseke is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Immunotherapy and Immune Responses (3 papers) and HIV Research and Treatment (2 papers). Clarety Kaseke collaborates with scholars based in United States, South Africa and China. Clarety Kaseke's co-authors include Fernando Senjobe, Rhoda Tano-Menka, Gaurav D. Gaiha, A. John Iafrate, Vivek Naranbhai, Wilfredo F. García-Beltrán, Anusha Nathan, Bruce D. Walker, Mary Carrington and Ashok Khatri and has published in prestigious journals such as Cell, The Journal of Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Clarety Kaseke

5 papers receiving 227 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals

2022 157 citations Vivek Naranbhai, Anusha Nathan et al. Cell profile →

Peers

Countries citing papers authored by Clarety Kaseke

Since Specialization

Citations

This map shows the geographic impact of Clarety Kaseke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarety Kaseke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarety Kaseke more than expected).

Fields of papers citing papers by Clarety Kaseke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarety Kaseke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarety Kaseke. The network helps show where Clarety Kaseke may publish in the future.

Co-authorship network of co-authors of Clarety Kaseke

This figure shows the co-authorship network connecting the top 25 collaborators of Clarety Kaseke. A scholar is included among the top collaborators of Clarety Kaseke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarety Kaseke. Clarety Kaseke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules 2024 ·Structure ·Rhoda Tano-Menka, Nishant K. Singh, (unknown), Xiaolong Li, (unknown), Clarety Kaseke, Charles R. Crain, Angela Zhang, Funsho Ogunshola, (unknown), Alicja Piechocka‐Trocha, Arman Bashirova, Michael E. Birnbaum, Mary Carrington, Bruce D. Walker, Gaurav D. Gaiha	1
2	A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta 2023 ·Frontiers in Immunology ·Brandon Carter, (unknown), Ge Liu, Yuejin Liang, Paulo J.C. Lin, Bi‐Hung Peng, Lindsay G. A. McKay, (unknown), Jason Hsu, (unknown), (unknown), Jinjin Chen, Clarety Kaseke, Gaurav D. Gaiha, Qiaobing Xu, Anthony Griffiths, Ying K. Tam, Chien‐Te K. Tseng, David K. Gifford	3
3	T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals breakdown → 2022 ·Cell ·Vivek Naranbhai, Anusha Nathan, Clarety Kaseke, Cristhian Berrios, Ashok Khatri, (unknown), Matthew A. Getz, Rhoda Tano-Menka, Onosereme Ofoman, Alton C. Gayton, Fernando Senjobe, Zezhou Zhao, Kerri St. Denis, Evan C. Lam, Mary Carrington, Wilfredo F. García-Beltrán, Alejandro B. Balazs, Bruce D. Walker, A. John Iafrate, Gaurav D. Gaiha	157
4	Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses 2021 ·Cell ·Anusha Nathan, Elizabeth J. Rossin, Clarety Kaseke, Ryan J. Park, Ashok Khatri, Dylan Koundakjian, Jonathan M. Urbach, Nishant K. Singh, Arman Bashirova, Rhoda Tano-Menka, Fernando Senjobe, Michael T. Waring, Alicja Piechocka‐Trocha, Wilfredo F. García-Beltrán, A. John Iafrate, Vivek Naranbhai, Mary Carrington, Bruce D. Walker, Gaurav D. Gaiha	53
5	The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts 2020 ·The Journal of Infectious Diseases ·Clarety Kaseke, Rhoda Tano-Menka, Fernando Senjobe, Gaurav D. Gaiha	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact